CoreCap Advisors’s Transmedics TMDX Stock Holding History

CoreCap Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-125	Closed	-$15.2K	–	3063
2025 Q4	$15.2K	Buy	+125	New	+$15.7K	﹤0.01%	1795
2025 Q3	–	Sell	-375	Closed	-$50.3K	–	2941
2025 Q2	$50.3K	Buy	375 +363	+3,025%	+$39.9K	﹤0.01%	1260
2025 Q1	$807	Buy	12 +5	+71%	+$344	﹤0.01%	2577
2024 Q4	$436	Sell	7 -593	-99%	-$55.2K	﹤0.01%	2567
2024 Q3	$94.2K	Buy	600 +180	+43%	+$27.7K	﹤0.01%	939
2024 Q2	$63.3K	Buy	+420	New	+$50.4K	0.01%	606

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CoreCap Advisors's TMDX Position: Q1 2026 in Review

CoreCap Advisors sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 125 shares — an estimated $15.2K sold.

CoreCap Advisors first reported a position in TMDX in Q2 2024 and held it in 6 quarters. The position peaked at $94.2K in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

CoreCap Advisors reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
CoreCap Advisors sold 125 Transmedics shares in Q1 2026, an estimated $15.2K.
CoreCap Advisors first reported a position in Transmedics in Q2 2024 and held it in 6 quarters.
CoreCap Advisors's Transmedics position peaked at $94.2K in Q3 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on CoreCap Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.